Targeting oral cancer
Project team Manijeh Goldberg with Erkin Ayden, Kuan Chen, and Gurtej Singh
Topical drug delivery
The current treatment of oral cancer is to intravenously administer a highly toxic chemotherapy drug with systemic side effects. This project is developing a topical delivery of anti-cancer drugs that can significantly reduce the side effects while allowing for a more effective cancer treatment.
The technology from this project was spun out into a startup company, Privo Technologies.